MRC1 and Lynch syndrome: The lack of MMR-DCF in patients with sporadic MSI-H colorectal cancer may result from a distinct pathway of tumour development that, in contrast to abrupt loss of MLH1 in Lynch syndrome-associated lesions, encompasses a gradual decrease of MLH1 protein expression due to increasing epigenetic changes [23,24].